Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 6 to 12

DYMOND: TrackSight peripheral-vision myopia control for children

Official title: Randomized Controlled Double Masked, Trial to Assess the Efficacy and Safety of a DYnaMic Peripheral DegradatiON Myopia Disorder Control in Myopic Children Compared to No Treatment (DYMOND Study)

Run by NovaSight · NCT07390500 · Data updated 2026-11-12

This study will see if TrackSight, an eye-tracking app, can slow nearsightedness progression in children aged 6–12 during their regular screen use.

Quick facts

PhasePhase 2
Study typeInterventional
Ages6 Years to 12 Years
SexAll
Enrollment150 (estimated)
SponsorNovaSight
Industry-sponsored
Locations1 site (Rehovot)
StatusRecruiting
StartedDecember 24, 2025
Main results expectedJune 2027
Study endsAugust 2027
Registry record updatedFebruary 5, 2026
Trial IDNCT07390500 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 6–12 with cycloplegic spherical equivalent between −0.75 D and −5.00 D, astigmatism ≤1.50 D, currently wearing single-vision glasses, and who use digital devices at least one hour per day.

Probably not a fit

Children already using other myopia control treatments, with ocular disease, prior ocular surgery, or refractive errors outside the enrollment ranges are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Up to 150 children with mild to moderate myopia at sites in Israel and Hong Kong will be randomized to use TrackSight with one of two active peripheral-adjustment settings or a non-adjusting control while continuing their usual single-vision glasses for 12 months. TrackSight uses real-time eye tracking to keep central vision clear while applying controlled visual changes to peripheral screen areas intended to influence eye growth. Participants will have baseline, 6-month, and 12-month eye exams and safety assessments including refraction and axial length measurements. The trial compares progression rates and safety outcomes between groups to determine whether the digital approach reduces myopia progression during everyday screen use.

Why it matters

Potential benefit: If successful, the app could provide a noninvasive way to slow childhood myopia progression without changing eyeglass prescriptions or adding drugs or contact lenses.

How similar studies have gone: Specialized spectacle and contact lens approaches that create peripheral defocus have shown reductions in myopia progression, but software-delivered peripheral defocus during screen use is a newer approach with limited prior clinical data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged 6-12 years

  -. Diagnosed with myopia: cycloplegic spherical or spherical equivalent (SER) between -0.75D and -5.00D, astigmatism ≤ -1.50D, anisometropia \< 1.50D
* Visual acuity 20/32 or better (age-appropriate testing) in both eyes
* Interocular VA difference ≤1.00 logMAR line
* Subject in general good health and able, as per investigator decision, to comply with study visits and protocol procedures
* The subject is using digital devices for at least 1 hour/day regularly according to parental report
* Signed informed consent by legal parent/guardian and assent approval -. Currently wearing single vision refractive correction

Exclusion Criteria:

* Past or concurrent use of any other myopia treatment (e.g., atropine, orthokeratology, myopia control glasses/lenses)
* Eye diseases or abnormality, developmental conditions, or past ocular surgeries or any other condition which could potentially affect refraction or AL progression according to the investigator's judgement
* Current or prior history of manifest strabismus, amblyopia, or nystagmus
* Subject cannot pass eye tracking calibration in at least 50% of cases, or cannot be tracked in at least 50% of the time during a screening eligibility test
* Current or previous use of bifocal lenses, progressive-addition lenses, or multi-focal contact lenses
* Premature gestational age ≤32 weeks or birth weight \<1500g.

Where it's running

  • Kaplan MC
    Rehovot, Israel
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.